SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (25402)9/13/1998 11:54:00 PM
From: Mike McFarland  Read Replies (1) | Respond to of 32384
 
CD154?

Mackey, M.F.; Gunn, J.R.; Ting, P.P.; Kikutani, H.; Dranoff, G.; Noelle, R.J.; Barth, R.J. "Protective Immunity Induced by Tumor Vaccines Requires Interaction Between CD40 and Its Ligand, CD154." Cancer Research, July 1 1997;57(13):2569-2574.

I also have these two links
bdfacs.com
researchd.com

Sorry to be essentially data mining and then just blurting
out the results here on the Ligand thread--but I searched
on the Ligand website and did not find anything--maybe I
entered my search query incorrectly...

--MM



To: Mike McFarland who wrote (25402)9/14/1998 12:53:00 AM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
To my knowledge, LGND is also not involved in CD-40 ligands either.